These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3873988

  • 21. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL, Wu MS, Chen Z.
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [Abstract] [Full Text] [Related]

  • 22. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C, Archetti YL, Aresca P, Del Vecchio L.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [Abstract] [Full Text] [Related]

  • 23. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells.
    Miura T, Nogiwa E, Kurashige S, Maekawa T.
    Cancer Res; 1980 Dec; 40(12):4813-6. PubMed ID: 7438114
    [Abstract] [Full Text] [Related]

  • 24. Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity.
    Kataoka T, Oh-hashi F, Sakurai Y.
    Gan; 1979 Apr; 70(2):155-64. PubMed ID: 111995
    [Abstract] [Full Text] [Related]

  • 25. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H.
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [Abstract] [Full Text] [Related]

  • 26. Environmental conditions favorable for tumor progression in peritoneal cavity induced by peritoneal cells without tumor selectivity.
    Segawa K, Ueno Y, Kataoka T.
    Jpn J Exp Med; 1989 Jun; 59(3):127-33. PubMed ID: 2681889
    [Abstract] [Full Text] [Related]

  • 27. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Venditti M, Carlei D, Belardelli F.
    J Clin Invest; 1998 Jan 15; 101(2):429-41. PubMed ID: 9435316
    [Abstract] [Full Text] [Related]

  • 28. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
    Nicolin A, Canti G, Marelli O, Veronese F, Goldin A.
    Cancer Res; 1981 Apr 15; 41(4):1358-62. PubMed ID: 7011535
    [Abstract] [Full Text] [Related]

  • 29. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI, Taraban VY, Seledtsova GV, Samarin DM, Avdeev IV, Senyukov VV, Kozlov VA.
    Cell Immunol; 1997 Nov 25; 182(1):12-9. PubMed ID: 9427805
    [Abstract] [Full Text] [Related]

  • 30. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
    Yokochi T, Kawashima K, Nakashima I, Nagase F, Isobe K, Nagura E, Yamada K, Miyadai T, Kimura Y.
    Cancer Res; 1987 Feb 15; 47(4):1006-9. PubMed ID: 3542198
    [Abstract] [Full Text] [Related]

  • 31. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu, Sokolova IS, Bakhmedova AA, Miniker TD, Mel'nik SIa, Gorbacheva LB.
    Biokhimiia; 1995 Sep 15; 60(9):1521-9. PubMed ID: 8562657
    [Abstract] [Full Text] [Related]

  • 32. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH, Currie D, Hwang KM.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [Abstract] [Full Text] [Related]

  • 33. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor.
    Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1977 Dec 15; 37(12):4416-9. PubMed ID: 922733
    [Abstract] [Full Text] [Related]

  • 34. Cellular mechanism of primary anti-Thy-1 antibody responses in vitro induced by uniquely immunogenic thymocyte antigens.
    Isobe KI, Nakashima I, Nagase F, Kato N, Mizoguchi K, Kawashima K, Lake P.
    J Immunol; 1984 Mar 15; 132(3):1100-5. PubMed ID: 6141204
    [Abstract] [Full Text] [Related]

  • 35. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 36. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD, Lahaye T, Sorenson GD, Glasebrook AL, Horvath C, Brunner KT.
    J Immunol; 1984 Sep 15; 133(3):1664-70. PubMed ID: 6205090
    [Abstract] [Full Text] [Related]

  • 37. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
    Kataoka T.
    Gan To Kagaku Ryoho; 1986 Mar 15; 13(3 Pt 2):701-5. PubMed ID: 3963841
    [Abstract] [Full Text] [Related]

  • 38. [Production by activated lymphocytes of mediators increasing the antitumor cytostatic activity of bone marrow cells].
    Seledtsov VI, Taraban VIa, Seledtsova GV, Seniukov VV, Samarin DM, Kashchenko EA, Kozlov VA.
    Biull Eksp Biol Med; 1998 Jun 15; 125(6):660-2. PubMed ID: 9693761
    [No Abstract] [Full Text] [Related]

  • 39. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S, Wachowski O, Zerban H, Schirrmacher V, Umansky V, Rocha M.
    Clin Cancer Res; 1998 Dec 15; 4(12):3095-106. PubMed ID: 9865926
    [Abstract] [Full Text] [Related]

  • 40. Establishment of a murine leukemia L1210-specific T-cell clone displaying novel in vivo anti-tumor activity.
    Nagase F, Ueda K, Nakashima I, Kawashima K, Isobe K, Nagura E, Yamada K, Yokochi T, Hasegawa Y, Yoshida T.
    Int J Cancer; 1986 Dec 15; 38(6):907-14. PubMed ID: 3491792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.